Evidence map›Paper›PMID 34508545›Full record

ArticleAmerican journal of clinical pathology2022

Global Cytopathology-Hematopathology Practice Trends.

Sara L Zadeh, Ronald Balassanian, Matthew C Cheung, Lorenzo Falchi, Robert Hasserjian, Oscar Lin, Steven R Long, Amy Ly, Joshua R Menke, Eric Mou and 6 more

Erratum issuedOpen access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of clinical pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 2 countries.

Sara L ZadehDepartment of Pathology, Stanford University, Stanford, CA, USA.
Ronald BalassanianDepartment of Pathology, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Matthew C CheungDepartment of Medicine, Division of Hematology/Oncology, University of Toronto, Toronto, Canada.
Lorenzo FalchiDepartment of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Robert HasserjianDepartment of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Oscar LinDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Steven R LongDepartment of Pathology, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Amy LyDepartment of Pathology, Massachusetts General Hospital, Boston, MA, USA.
Joshua R MenkeDepartment of Pathology, Stanford University, Stanford, CA, USA.
Eric MouCollege of Medicine, Division of Hematology, University of Iowa, Iowa City, IA, USA.ORCID 0000-0002-9865-4517
Yasodha NatkunamDepartment of Pathology, Stanford University, Stanford, CA, USA.
Roberto Ruiz-CorderoDepartment of Pathology, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Ashley K VolaricDepartment of Pathology, Stanford University, Stanford, CA, USA.ORCID 0000-0001-9585-812X
Linlin WangDepartment of Laboratory Medicine, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Kwun Wah WenDepartment of Pathology, University of California, San Francisco (UCSF), San Francisco, CA, USA.
Dita GratzingerDepartment of Pathology, Stanford University, Stanford, CA, USA.
Stanford University · USUniversity of California, San Francisco · USMassachusetts General Hospital · USMemorial Sloan Kettering Cancer Center · USUniversity of Iowa · USUniversity of Toronto · CA

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748Stanford Pathology Department's Value-Based Care in Pathology Award
6 · The paper itself

Abstract

objectivesSmall-volume biopsy-fine-needle aspiration biopsy (FNAB) with or without core biopsy-is in increasing use in diagnosis and management of lymphoma patients. Our objective was to survey the current practice in small-volume biopsy diagnosis of lymphoma, focusing on the interaction among hematopathologists and cytopathologists and the integration of FNAB, core biopsy, and flow cytometry studies at sign-out.

methodsThis study used a cross-sectional survey design employing the RedCap database distributed via nine pathology professional society email listservs. The survey consisted of 25 multiple-choice questions and several free text fields. In total, 128 pathologists participated.

resultsMost respondents indicated that FNAB specimens in which lymphoma is a diagnostic consideration (FNAB-L) are seen daily or weekly (68/116; 58.6%). However, most institutions have separate hematopathology and cytopathology services (72/116; 62.1%) with inconsistent communication. When communication occurred, respondents were frequently inclined to reconsider their original diagnoses. Barriers identified included lack of communication, inadequate access to diagnostic studies, no formal subspecialty training, and various opinions regarding FNAB in diagnosing lymphoma.

conclusionsThis survey showed that FNAB-L specimens are common, with a lack of uniformity in how complementary fine-needle aspiration and core biopsy specimens or flow immunophenotyping results are shared across hematopathology and cytopathology services.

Indexed as

PathologistsBiopsy, Fine-NeedleBiopsy, Large-Core NeedleCross-Sectional StudiesHumansImmunophenotypingCytopathologyFine-needle aspirationFlow cytometryHematopathologyLymphoma

Identifiers

PMID34508545
PMCPMC9630120
OpenAlexW3198471783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.